Literature DB >> 3680308

The effect of the virus-serum incubation period upon vaccinia virus serum neutralization titers.

J B Katz1.   

Abstract

Rabbit and human vaccinia virus immune sera were titrated by the plaque reduction serum neutralization (SN) method. Titers determined following a 2-h, 37 degree C virus-serum incubation period were not significantly different from those determined following an 18-h incubation period (2-h, 37 degree C incubation followed by a 16-h, 4 degree C period). However, control virus plaque counts decreased significantly after the longer incubation period. Numerous factors affecting SN titer estimation are reviewed. Standardization of SN test conditions may be useful in comparative potency evaluation of vaccinia-vectored recombinant DNA viral vaccines.

Entities:  

Mesh:

Year:  1987        PMID: 3680308     DOI: 10.1016/s0092-1157(87)80013-6

Source DB:  PubMed          Journal:  J Biol Stand        ISSN: 0092-1157


  3 in total

1.  Improved assay to detect neutralizing antibody following vaccination with diluted or undiluted vaccinia (Dryvax) vaccine.

Authors:  Frances K Newman; Sharon E Frey; Tamara P Blevins; Mahendra Mandava; Andres Bonifacio; Lihan Yan; Robert B Belshe
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

2.  Neutralization assay using a modified vaccinia virus Ankara vector expressing the green fluorescent protein is a high-throughput method to monitor the humoral immune response against vaccinia virus.

Authors:  Antonio Cosma; Silja Bühler; Rashmi Nagaraj; Caroline Staib; Anna-Lena Hammarin; Britta Wahren; Frank D Goebel; Volker Erfle; Gerd Sutter
Journal:  Clin Diagn Lab Immunol       Date:  2004-03

3.  A novel high-throughput vaccinia virus neutralization assay and preexisting immunity in populations from different geographic regions in China.

Authors:  Qiang Liu; Weijin Huang; Jianhui Nie; Rong Zhu; Dongying Gao; Aijing Song; Shufang Meng; Xuemei Xu; Youchun Wang
Journal:  PLoS One       Date:  2012-03-16       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.